Lawyers

Search rankings
  • search
Bart Lintermans
Bart Lintermans
Bart Lintermans heads the Quinz M&A practice and is a specialist in M&A, commercial transactions and Belgian company law. For twenty-five years, Bart Lintermans has applied this expertise in a variety of sectors, but has a particular focus on the life science industry and real estate market. He advises Belgian and international private equity funds on their acquisitions and divestitures throughout Belgium and cross-border, and is the trusted advisor of several large companies in their international expansion, restructuring projects and corporate governance. Bart sits on various boards and is a former director of Brussels South Charleroi Airport, Belgium’s second largest commercial airport.    
Benoît Allemeersch
Benoît Allemeersch
A respected litigator and negotiator, Benoît Allemeersch represents clients before civil and criminal courts in Belgium, as well as in national and international arbitration. The focus of his dispute resolution practice is on complex commercial, financial and corporate disputes and he frequently consults on cross-border litigation. His experience includes appointments as an arbitrator and a mediator. He combines his law practice with an academic career, as tenured professor at the Catholic University of Leuven, where he teaches Belgian and European civil procedure law and evidence law. He is widely published in various subjects relating to national and EU procedural law, conflicts of law, evidence and criminal law. He also advises the Belgian legislator and government on a regular basis.
Marion Lapage
Marion Lapage
Marion is a corporate lawyer specializing in the life sciences sector, with a particular focus on the pharmaceutical, medical devices, and consumer healthcare industries. She advises clients on strategic transactions and complex regulatory matters, with an emphasis on market access and supply chain challenges. Marion has deep expertise in supply chain-related transactions, including supply agreements, logistics services, and distribution set-ups, and regularly advises on the regulatory aspects of these operations. Her practice also includes providing strategic counsel on licensing (in- and out-), acquisitions, and divestments of life sciences products. She has extensive experience managing transactions throughout the entire product life cycle, from R&D outsourcing and technical operations to commercial supply arrangements and distribution networks.
Olivier Van Obberghen
Olivier Van Obberghen
Olivier Van Obberghen is an R&D, commercial transactions and M&A lawyer with a focus on the Life Sciences and Innovative Technologies sectors.  He also advises companies active in the consumer goods and media industries. His Life Sciences practice has three main areas of expertise: (i) transactional work (R&D and supply chain contracts; distribution; licensing and M&A), (ii) compliance advice (transparency; promotion of drug products; patient involvement) and (iii) regulatory assistance.
Stijn De Dier
Stijn De Dier
At Quinz, Stijn focuses primarily on dispute resolution. His practice circles around corporate litigation (shareholder disputes, director liability, post-acquisition claims, ESG litigation etc.) as well as insolvency matters, where he regularly acts both for creditors as well as for debtors in restructuring. Stijn is appreciated by clients and colleagues for his profound expertise in corporate law and his pragmatic problem-solving approach. Prior to joining Quinz, Stijn worked at the Jan Ronse Institute for company and financial law of KU Leuven, first as a full time assistant, and later on as a fellow of the Research Foundation – Flanders (FWO). Upon his Ph.D. defense in April 2016 he remains associated with the Jan Ronse Institute on a voluntary basis. Stijn is a part time professor at the Antwerp University Faculty of Law, where he teaches insolvency law. Stijn also sits on the editorial board of the Tijdschrift voor Rechtspersoon en Vennootschapsrecht - Revue Pratique des Sociétés (TRV-RPS) and is a member of the Belgian Centre for Corporate Law (BCV-CDS). He frequently speaks at conferences or seminars, and publishes on various aspects of company and insolvency law.